Wantstats
Company ProfilePremium

Prometheus Laboratories Inc.

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
Prometheus Laboratories Inc. - Healthcare showcase

Year Founded & Workforce

1995

Industry

Healthcare

Services

NASH test
P

Prometheus Laboratories Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Prometheus Laboratories Inc. Overview

Company Headquarters: California, US

Founded: 1995

Company Working: Prometheus Laboratories Inc. (Prometheus) is engaged in the development and commercialization of pharmaceutical and diagnostic products that enable physicians to provide individualized patient care. The company offers Anser IFX and Anser ADA monitoring assays, non-invasive tests, and inflammation markers in the smart diagnostic algorithm for added diagnostic clarity, celiac tests, and thiopurine monitoring tests, among others. Prometheus operates as a subsidiary of Nestlé.

Strategy

Prometheus focuses on increasing R&D investments to bring quality products to its customers. Moreover, the company aims to broaden its product portfolio in the coming years. The company also aims to expand its presence in untapped markets.

Company Snapshot

$87,286.8M

Revenue

1995

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • Increasing regional presence
  • Rising brand loyalty

Weaknesses

  • Limited product portfolio

Opportunities

  • Strategic collaborations and partnerships

Threats

  • Changing regulatory policies
  • Growing competition in the market

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
October 2017Product LaunchPrometheus introduced the FIBROSpect NASH test, a tool to help healthcare providers stratify NASH patients based on the severity of their liver fibrosis. With this, the company aims to scale up its position in the global NASH biomarkers market.

Product Offering

  • Prometheus Laboratories Inc.
    • NASH test

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 87,286.8 Mn in 2016 to USD 93,400.4 Mn in 2018.
Prometheus Laboratories Inc. — By Business Segment
Series (USD Mn)201620172018
Sales87,286.887,490.393,400.4
R&D Expenditure1,693.71,698.21,723.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →